Coinfection: all 92 studies

Page 1 of 1. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT07681583
• Community-acquired Pneumonia Due to Chlamydia PneumoniaeNot yet recruitingNCT07679789
• BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and RadiomicsRecruitingNCT07633366
• Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East AustriaRecruitingNCT06834178
• Role of Transposable Elements in Septic Immune AgingRecruitingNCT06809868
• Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppressionRecruitingNCT06774235Phase 3
• Host Immunity, Plasmodium and Pathogens Co-InfectionsNot yet recruitingNCT06769815Not applicable
• Emergency PWAS in Respiratory Infectious DiseaseRecruitingNCT05336851
• Prospective Cohort of HIV/HBV-coinfected Patients in EuropeEnrolling by invitationNCT04984772
• Effect of Sofosbuvir-daclatasuvir on AngiogenesisRecruitingNCT03646396Not applicable
• EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVEnrolling by invitationNCT02699736
• Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?RecruitingNCT01904188
• Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected AdultsCompletedNCT03547908Phase 3Results posted
• A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral DrugsCompletedNCT03537404Phase 1Results posted
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-InfectionCompletedNCT02457611Phase 2Results posted
• Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan ChildrenActive, not recruitingNCT02414399Phase 4Results posted
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionCompletedNCT02178592Phase 3Results posted
• Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCVCompletedNCT02124044Phase 2Results posted
• Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected AdultsCompletedNCT02071082Phase 3Results posted
• Sonoelastography: Ultrasound Method to Measure Liver FibrosisCompletedNCT01747772Not applicableResults posted
• HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /RibavirinTerminatedNCT01718301Phase 3Results posted
• Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic DermatitisCompletedNCT01064947Phase 4Results posted
• A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)CompletedNCT00959699Phase 2Results posted
• Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin ResistanceCompletedNCT00665353Phase 2Results posted
• Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized AdultsCompletedNCT06779175
• Model to Predict Coinfection in Elderly Patients With COVID-19CompletedNCT06321367
• Intervention to Prevent Household and Community Spread of COVID-19 Among LatinosActive, not recruitingNCT05697068Not applicable
• Virus Interactions in the Respiratory Tract; a Cohort Study With ChildrenCompletedNCT05318235
• Risks of Bacterial and Fungal Superinfection in Patients With COVID-19CompletedNCT05256316
• Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19CompletedNCT05188482
• COVID-19 Serology in People Living with HIV in Hong KongCompletedNCT05028881
• Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French GuianaStatus unknownNCT04886102
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant BacteriaStatus unknownNCT04839653Not applicable
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyStatus unknownNCT04768517
• LILLE COVID RESEARCH NETWORK (Covid-19)CompletedNCT04475211
• Pediatric Immune Response to Multi-Organ DysfunctionCompletedNCT04438460Not applicable
• Microbiota in COVID-19 Patients for Future Therapeutic and Preventive ApproachesStatus unknownNCT04410263
• NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHCStatus unknownNCT04405011Not applicable
• Inflammation and Co-Infections in D²EFTWithdrawnNCT04183738Phase 4
• Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV CoinfectionCompletedNCT03800407
• Pharmacokinetics of Intracellular TFV-DP and FTC-TP in HIV-infected AdolescentsCompletedNCT03800394
• Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) TabletCompletedNCT03800381
• A Comprehensive HBsAg-positive Patients Centered Screening StrategyCompletedNCT03794791
• Efficacy, Safety and Pharmacokinetics of DTG With RIFCompletedNCT03731559Phase 2
• Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West AfricaCompletedNCT03711721Not applicable
• Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir FailureCompletedNCT03549832Not applicable
• Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyStatus unknownNCT03549312Phase 4
• Biomarkers of Acute Serious Illness in ChildrenCompletedNCT03238040
• Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1BCompletedNCT03050905Phase 4
• Predicting Visceral Leishmaniasis in HIV Infected PatientsTerminatedNCT03013673
• Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)TerminatedNCT02762383Phase 3
• Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisWithdrawnNCT02734186Phase 4
• The Impact of Anthelmintic Treatment on the Incidence of Diarrheal Disease in Vietnamese School ChildrenWithdrawnNCT02597556Phase 4
• DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
• Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic MarkersCompletedNCT02427360
• A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-InfectionCompletedNCT02339337Phase 4
• Effects of Viral and Bacterial Co-infections in Otherwise Healthy Children Hospitalized in Pediatric DepartmentCompletedNCT02325102
• Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV CoinfectionCompletedNCT02294136Not applicable
• Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From GhanaCompletedNCT02281643Phase 2
• Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth InfectionTerminatedNCT02225158
• Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)CompletedNCT02109887
• Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TBCompletedNCT01805258Phase 3
• Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null RespondersCompletedNCT01725542Phase 2
• Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaCompletedNCT01425073Not applicable
• Prevalence of Occult HBV Infection Among Anti-HBc Alone Group in Northern TaiwanStatus unknownNCT01396538
• Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infectionCompletedNCT01231685Phase 2
• HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With FosamprenavirCompletedNCT01222611Phase 4
• Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug UsersStatus unknownNCT01105611Phase 4
• Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?TerminatedNCT00817713Not applicable
• Hepatitis B and HIV Co-Infection in Patients in UgandaCompletedNCT00782158
• Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV TherapyCompletedNCT00747539
• Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTCompletedNCT00719602Early Phase 1
• Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)Status unknownNCT00662194
• A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected PatientsStatus unknownNCT00660361
• Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4CompletedNCT00612755Phase 4
• Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCVStatus unknownNCT00611819Phase 4
• Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIVCompletedNCT00545558Phase 1
• A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIVTerminatedNCT00523458Phase 4
• Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease ProgressionCompletedNCT00507221Not applicable
• Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With TuberculosisStatus unknownNCT00474435Phase 2
• Medical Implications of Coinfection With Malaria and Filariasis ParasitesCompletedNCT00471666
• A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3
• Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIVCompletedNCT00356486Phase 4
• Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
• Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesCompletedNCT00341666
• Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)TerminatedNCT00340548
• Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in CameroonCompletedNCT00209313Phase 2/3
• Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune ActivationCompletedNCT00130910Not applicable
• Zidovudine Levels in HIV Infected Patients Being Treated for HCVCompletedNCT00059358Phase 1/2
• The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinCompletedNCT00031343Phase 2

← Coinfection overview